FDA Approved: DALFAMPRIDINE — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

FDA approved Actavis Pharma, Inc.'s supplemental application for dalfampridine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Dalfampridine (dalfampridine)

Snippet

SUPPL AP for DALFAMPRIDINE (DALFAMPRIDINE)